Human Studies Start for Promising COVID-19 Treatment Discovered by LSU DeepDrug Team Using Artificial Intelligence
August 12, 2021
August 12, 2021
BATON ROUGE, Louisiana, Aug. 12 (TNSRes) -- Louisiana State University issued the following news release on Aug. 11, 2021:
* * *
New combination of already FDA-approved compounds can prevent extreme and lasting symptoms, cut hospitalizations.
* * *
Skymount Medical, a drug discovery company based in Canada, and Louisiana State University (LSU) announced today that human studies have begun on its unique combination of therapies for COVID-19 pati . . .
* * *
New combination of already FDA-approved compounds can prevent extreme and lasting symptoms, cut hospitalizations.
* * *
Skymount Medical, a drug discovery company based in Canada, and Louisiana State University (LSU) announced today that human studies have begun on its unique combination of therapies for COVID-19 pati . . .